HLS Therapeutics Inc (OTCPK:HLTRF)
$ 2.73 0.19 (7.48%) Market Cap: 83.68 Mil Enterprise Value: 134.75 Mil PE Ratio: 0 PB Ratio: 1.02 GF Score: 58/100

HLS Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 17, 2022 / 02:00PM GMT
Release Date Price: $10.96
Operator

Hello, and welcome to the Annual Meeting of Shareholders of HLS Therapeutics, Inc. Please note that today's meeting is being recorded. (Operator Instructions) It is now my pleasure to turn today's meeting over to Ryan Lennox, Senior Vice President, Law, HR and Compliance of HLS Therapeutics, Inc. The floor is yours.

Ryan C. Lennox
HLS Therapeutics Inc. - Senior VP of Legal, HR & Compliance and Corporate Secretary

Good morning, and welcome to the Annual Meeting of Shareholders of HLS Therapeutics, Inc. taking place today June 17 at 10:00 a.m. Eastern Time.

Thank you, everyone, for your attendance today. My name is Ryan Lennox, and I'm the Corporate Secretary and Senior Vice President, Law, HR and Compliance of HLS. I would like to briefly read the following forward-looking information statement before turning the meeting over to Greg Gubitz, as Chairman of the Board.

In the course of today's meeting, directors and officers of HLS may, in their remarks or in response to questions, make certain statements that are forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot